✦ LIBER ✦

A Phase 2 Study with Epirubicin as Second-Line Treatment of Patients with Advanced Epithelial Ovarian Cancer

✍ Scribed by Hanne Havsteen; Kamma Bertelsen; Carl C. Gadeberg; Anders Jacobsen; Claus Kamby; Erik Sandberg; Lisa Sengeløv

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine combined with cisplatin as f

✍ D Belpomme; I Krakowski; M Beauduin; T Petit; J.L Canon; J Janssens; S Gauthier; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Taxol as Second-Line Treatment in Patien

✍ K. Mayerhofer; E. Kucera; H. Zeisler; P. Speiser; A. Reinthaller; P. Sevelda 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Phase II study of weekly irinotecan (CPT

✍ J. Cassinello; P. López-Alvarez; A. Martínez-Guisado; M. Valladares; G. Huidobro 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 106 KB

Phase II study of flutamide as second li

✍ Jivesh J. Sharma; Betty Razvillas; C.D. Stephens; Susan G. Hilsenbeck; Ashu Shar 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 37 KB

Second-Line Treatment with Intravenous G

✍ Bruzzone, M.; Centurioni, M.G.; Giglione, P.; Gualco, M.; Merlo, D.F.; Miglietta 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 469 KB

Sorafenib as a third line therapy in pat

✍ Lubomir Bodnar; Maria Górnas; Cezary Szczylik 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 148 KB